Molecular and Cellular Biochemistry

, Volume 345, Issue 1–2, pp 119–130 | Cite as

Differential induction of cellular proliferation, hypertrophy and apoptosis in H9c2 cardiomyocytes by exogenous tissue factor

  • G. Alkistis Frentzou
  • Mary E. W. Collier
  • Anne-Marie L. Seymour
  • Camille Ettelaie


Recent evidence has shown that prolonged exposure to exogenous tissue factor (TF) can alter the cellular functions of cardiomyocytes resulting in cardiac dysfunction. The effect of TF may arise from local inflammation within or in the vicinity of the heart. The aim of this study was to investigate the effect of TF on cardiomyocyte proliferation and growth. H9c2 rat cardiomyocytes were exposed to a range of concentrations of recombinant TF (rTF) (1.3–52 ng/ml) for up to 10 days and the outcome on cell proliferation and induction of apoptosis measured. At lower concentrations examined (1.3 ng/ml), rTF had a proliferative influence on the H9c2 cells. In contrast, elevated concentrations of rTF (52 ng/ml) induced cellular apoptosis as indicated by increased caspase-3 activity and nuclear localisation of p53. Moreover, incubation with intermediate concentrations of rTF (13 ng/ml) resulted in an initial increase in proliferation but subsequently, led to cellular apoptosis by day 7 of the incubation. In order to determine if these effects induced hypertrophic cell growth, expression of mechano-growth factor (MGF) was analysed. Incubation of cells with rTF resulted in enhanced expression of MGF particularly at the intermediate concentrations of rTF (13 ng/ml) as well as mean cellular transverse diameter. In addition, there was a rapid increase in the expression of atrial natriuretic factor (ANF) in the cells, on incubation with rTF but diminished rapidly when exposed to higher concentrations of rTF. These data indicate that exposure to increasing concentrations of rTF can accelerate the rate of cardiomyocyte turnover which may ultimately lead to depletion of viable cells within the heart. Moreover, at lower concentrations of rTF, the induction of cell proliferation together with hypertrophic markers indicates that rTF may contribute to the induction and progression of cardiac hypertrophy.


Tissue factor H9c2 cardiomyocytes Proliferation Apoptosis MGF Hypertrophy 



We acknowledge the support of Heart Research UK for this work.


  1. 1.
    Spann JF Jr, Buccino RA, Sonnenblick EH, Braunwald E (1967) Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 21:341–354PubMedGoogle Scholar
  2. 2.
    Nadal-Ginard IB, Kajstura J, Leri A, Anversa P (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92:139–150CrossRefPubMedGoogle Scholar
  3. 3.
    Hang T, Jiang S, Wang C, Xie D, Ren H, Zhuge H (2007) Apoptosis and expression of uncoupling protein 2 in pressure overload induced left ventricular hypertrophy. Acta Cardiol 62:461–465CrossRefPubMedGoogle Scholar
  4. 4.
    Goldspink G (1999) Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J Anat 194:323–334CrossRefPubMedGoogle Scholar
  5. 5.
    Yang SY, Goldspink G (2002) Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 522:156–160CrossRefPubMedGoogle Scholar
  6. 6.
    Harridge SD (2003) Ageing and local growth factors in muscle. Scand J Med Sci Sports 13:34–39CrossRefPubMedGoogle Scholar
  7. 7.
    Coerper S, Wolf S, Von Kiparski S, Thomas S, Zittel TT, Ranke MB, Hunt TK, Becker HD (2001) Insulin-like growth factor I accelerates gastric ulcer healing by stimulating cell proliferation and by inhibiting gastric acid secretion. Scand J Gastroenterol 36:921–927CrossRefPubMedGoogle Scholar
  8. 8.
    Lloyd RV, Erickson LA, Nascimento AG, Kloppel G (1999) Neoplasms causing nonhyperinsulinemic hypoglycemia. Endocr Pathol 10:291–297CrossRefPubMedGoogle Scholar
  9. 9.
    Pawlinski R, Fernandes A, Kehrle B, Pedersen B, Parry G, Erlich J, Pyo R, Gutstein D, Zhang J, Castellino F, Melis E, Carmeliet P, Baretton G, Luther T, Taubman M, Rosen E, Mackman N (2002) Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci USA 99:15333–15338CrossRefPubMedGoogle Scholar
  10. 10.
    Camerer E, Huang W, Coughlin SR (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97:5255–5260CrossRefPubMedGoogle Scholar
  11. 11.
    Riewald M, Ruf W (2002) Orchestration of coagulation protease signaling by tissue factor. Trends Cardiovasc Med 12:149–154CrossRefPubMedGoogle Scholar
  12. 12.
    Peppelenbosch MP, Versteeg HH (2001) Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc Med 11:335–339CrossRefPubMedGoogle Scholar
  13. 13.
    Pradier A, Ettelaie C (2008) The influence of exogenous tissue factor on the regulators of proliferation and apoptosis in endothelial cells. J Vasc Res 45:19–32CrossRefPubMedGoogle Scholar
  14. 14.
    Ray B, Chetter IC, Lee HL, Ettelaie C, McCollum PT (2007) Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty. Br J Surg 94:1092–1095CrossRefPubMedGoogle Scholar
  15. 15.
    Breitenstein A, Tanner FC, Lüscher TF (2010) Tissue factor and cardiovascular disease: quo vadis? Circ J 74:3–12CrossRefPubMedGoogle Scholar
  16. 16.
    Muller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Scheider W, Gulba D, Ganten D, Haller H, Luft FC (2000) Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol 157:111–122PubMedGoogle Scholar
  17. 17.
    Chi L, Gibson G, Peng YW, Bousley R, Brammer D, Rekhter M, Chen J, Leadley R (2004) Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits. J Thromb Haem 2:85–92CrossRefGoogle Scholar
  18. 18.
    Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25:169–193CrossRefPubMedGoogle Scholar
  19. 19.
    Ettelaie C, Collier ME, James NJ, Li C (2007) Induction of tissue factor expression and release as microparticles in ECV304 cell line by Chlamydia pneumoniae infection. Atherosclerosis 190(2):343–351CrossRefPubMedGoogle Scholar
  20. 20.
    Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, Carrick FE, Bauriedel G, Luderitz B, Fallon JT, Fuster V, Badimon JJ (2004) Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 109:2001–2008CrossRefPubMedGoogle Scholar
  21. 21.
    Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656CrossRefPubMedGoogle Scholar
  22. 22.
    Camerer E, Huang W, Coughlin SR (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97:5255–5260CrossRefPubMedGoogle Scholar
  23. 23.
    Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A (2010) The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 26:140–145PubMedGoogle Scholar
  24. 24.
    Nagata S (1997) Apoptosis by death factor. Cell 88:355–365CrossRefPubMedGoogle Scholar
  25. 25.
    Gopisetty G, Ramachandran K, Singal R (2006) DNA methylation and apoptosis. Mol Immunol 43:1729–1740CrossRefPubMedGoogle Scholar
  26. 26.
    Ryan KM, Phillips AC, Vousden KH (2001) Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13:332–337CrossRefPubMedGoogle Scholar
  27. 27.
    Clerk A (2003) The radical balance between life and death. J Mol Cell Cardiol 35:02–599CrossRefGoogle Scholar
  28. 28.
    Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336CrossRefPubMedGoogle Scholar
  29. 29.
    Mackman N (1995) Regulation of tissue factor gene. FASEB 9:883–889Google Scholar
  30. 30.
    Yuchuan L, Pelekanakis K, Woolkalis MJ (2004) Thrombin and tumor necrosis factor α synergistically stimulate tissue factor expression in human endothelial cells: regulation through c-Fos and c-Jun. J Biol Chem 279:36142–36147CrossRefGoogle Scholar
  31. 31.
    Boateng SY, Seymour AM, Bhutta NS, Dunn MJ, Yacoub MH, Boheler KR (1998) Sub-antihypertensive doses of ramipril normalize sarcoplasmic reticulum calcium ATPase expression and function following cardiac hypertrophy in rats. J Mol Cell Cardiol 30:2683–2694CrossRefPubMedGoogle Scholar
  32. 32.
    Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H (1991) Brain natriuretic peptide as a novel cardiac hormone in humans Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402–1412CrossRefPubMedGoogle Scholar
  33. 33.
    Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, Mcgregor CG, Edwards WD, Schaff HV, JCJr Burnett (1993) Natriuretic peptide system in human heart failure. Circulation 88:1004–1009PubMedGoogle Scholar
  34. 34.
    Goldspink G (2002) Gene expression in skeletal muscle. Biochem Soc Trans 30:285–290CrossRefPubMedGoogle Scholar
  35. 35.
    Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99:348–353PubMedGoogle Scholar
  36. 36.
    Nieuwland R, Berckmans RJ, Mcgregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95:930–935PubMedGoogle Scholar
  37. 37.
    Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK (2002) Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106:2442–2447CrossRefPubMedGoogle Scholar
  38. 38.
    Hilfiker-Kleiner D, Landmesser U, Drexter H (2006) Molecular mechanisms in heart failure: focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. J Am Coll Cardiol 48:A56–A66CrossRefGoogle Scholar
  39. 39.
    van Amerongen MJ, Engel FB (2008) Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med 12:2233–2244CrossRefPubMedGoogle Scholar
  40. 40.
    Hosoda T, Kajstura J, Leri A, Anversa P (2010) Mechanisms of myocardial regeneration. Circ J 74:13–17CrossRefPubMedGoogle Scholar
  41. 41.
    Stastna M, Abraham MR, Van Eyk JE (2009) Cardiac stem/progenitor cells, secreted proteins, and proteomics. FEBS Lett 583:1800–1807CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • G. Alkistis Frentzou
    • 1
    • 2
  • Mary E. W. Collier
    • 1
  • Anne-Marie L. Seymour
    • 1
  • Camille Ettelaie
    • 1
  1. 1.Biomedical Section, Department of Biological SciencesUniversity of HullHullUK
  2. 2.Cardiovascular and Neuronal RemodellingLIGHT, University of LeedsLeedsUK

Personalised recommendations